Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Voyager Therapeutics (VYGR) Shares Outstanding: 2015-2025

Historic Shares Outstanding for Voyager Therapeutics (VYGR) over the last 8 years, with Sep 2025 value amounting to $55.5 million.

  • Voyager Therapeutics' Shares Outstanding rose 1.72% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 1.72%. This contributed to the annual value of $54.7 million for FY2024, which is 24.28% up from last year.
  • As of Q3 2025, Voyager Therapeutics' Shares Outstanding stood at $55.5 million, which was up 0.09% from $55.4 million recorded in Q2 2025.
  • In the past 5 years, Voyager Therapeutics' Shares Outstanding ranged from a high of $55.5 million in Q3 2025 and a low of $37.6 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding was $54.5 million (2024), whereas its average is $50.8 million.
  • Data for Voyager Therapeutics' Shares Outstanding shows a peak YoY rose of 25.05% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Voyager Therapeutics' Shares Outstanding stood at $37.9 million in 2021, then grew by 1.83% to $38.6 million in 2022, then increased by 14.05% to $44.0 million in 2023, then grew by 24.28% to $54.7 million in 2024, then rose by 1.72% to $55.5 million in 2025.
  • Its last three reported values are $55.5 million in Q3 2025, $55.4 million for Q2 2025, and $55.2 million during Q1 2025.